VISTAGEN THERAPEUTICS, INC. Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 18.18 thousand shares for the 9-month period ending 2014-12-31, per its 10-Q filed 2016-02-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2016-02-16
- VISTAGEN THERAPEUTICS, INC. incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2014-09-30 was 19.85K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month |
|---|---|---|
| 2014-12-31 | 18.18K shares 10-Q · filed 2016-02-16 | |
| 2014-09-30 | 19.85K shares 10-Q · filed 2015-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |